Joseph Kim, Inovio CEO (Andrew Harnik, AP Images)
Covid-fattened shares crash as FDA puts a late-stage coronavirus vaccine trial on hold
After seeing its market cap soar on the prospects of a highly-touted Covid-19 vaccine, Inovio saw its share price $INO led to slaughter …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
